Federal Agency for Medicines and Health Products (FAMHP) famhp.be

Jascayd

Imported from official source

October 07, 2026 12:03 Announcement

Safety Classified by Officially

Jascayd Active substance Nerandomilast Titulaire Boehringer Ingelheim International GmbH Holder Running Indication Treatment of adult patients with idiopathic pulmonary fibrosis Public documents Approbation Information for the patient Informed consent Last update 07/10/2026 valerie.coqu Wed, 10/07/2026 - 14:11

Read the original at the source: https://www.famhp.be/fr/usage_humain/medicaments/medicaments/recherche_developpement/usage_compassionnel_programmes_134

Officially imported this from Federal Agency for Medicines and Health Products (FAMHP)’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization: Federal Agency for Medicines and Health Products (FAMHP) — imported from official source
Official source: https://www.famhp.be/en/rss.xml RSS
Imported: October 07, 2026 12:36
Versions: 1 recorded
Identity: 110405 at https://www.famhp.be